Notably, pharmacological scavenging of ROS or genetic suppression of p53 effectively rescues cell viability and prevents apoptosis in CREPT-knockdown gastric cancer cells, confirming the ROS–p53–p21 axis as a key downstream pathway regulated by CREPT (Figure 3). This evidence concerns the gene TP53 and gastric cancer.